Researchers Database

ISHIDA Tomoaki

    Lecturer
Last Updated :2026/08/29

Researcher Information

Degree

  • Ph.D(2020/03 Kochi University)

J-Global ID

Academic & Professional Experience

  • 2025/04 - Today  Nagoya City UniversityGraduate School of Pharmaceutical Sciences Department of Clinical Pharmacy講師
  • 2016/04 - 2025/03  高知大学医学部付属病院薬剤部

Education

  •        - 2020/03  Kochi University  Medical School
  •        - 2016/03  Nagoya City University  Medicin  Medicin

Association Memberships

  • 和漢医薬学会   日本医療薬学会   日本生薬学会   日本薬学会   

Published Papers

MISC

Industrial Property Rights

Awards & Honors

  • 2024/11 医療薬学会 優秀発表賞
     急性非代償性心不全患者における服薬アドヒアランス評価スコアの作成
  • 2020/09 和漢医薬学会 年会優秀発表賞
     配糖体の薬物動態と腸内細菌叢の関係性 -経口抗生剤負荷マウスにおけるグリチルリチン酸の体内動態の解析-
  • 2018/03 日本薬学会 学生優秀発表賞
     フレイルに対する漢方薬の有効性に関する検討~糖尿病性サルコペニアに対する十全大補湯の予防効果~
  • 2015/08 日本生薬学会 年会優秀発表賞
     サルコぺニアに対する牛車腎気丸の緩和作用とその有効成分の探索

Research Grants & Projects

  • 日本学術振興会:科学研究費助成事業
    Date (from‐to) : 2025/04 -2028/03 
    Author : 石田 智滉; 合田 光寛; 川田 敬; 石澤 啓介; 浜田 幸宏; 常風 興平
  • 日本学術振興会:科学研究費助成事業 若手研究
    Date (from‐to) : 2022/04 -2026/03 
    Author : 石田 智滉
  • Japan Society for the Promotion of Science:Grants-in-Aid for Scientific Research Grant-in-Aid for Early-Career Scientists
    Date (from‐to) : 2019/04 -2022/03 
    Author : Ishida Tomoaki
     
    The objective of this study was to find kampo medicines that could be a potential therapeutic agent for sarcopenia in diabetic patients. First, a primary screening was conducted using in vitro assays with Sirtuin1 (Sirt1) transcriptional activity in C2C12 cells. Next, the selected herbal medicines were evaluated effect on muscle atrophy using KKAy mice, a diabetic-obese model mouse. As a result, it was found that saikokeishikankyoto and juzentaihoto alleviates muscle atrophy in KKAy mice. Furthermore, juzentaihoto also alleviated an inhibitory effect on muscle atrophy in senescence-accelerated mice (SAMP8). These results suggest that saikokeishikankyoto and juzentaihoto may have preventive effects against sarcopenia in diabetic patients.

Media Coverage

  • 便秘の合併は心不全患者の死亡率上昇と関連
    Date : 2025/02/04
    Writer: Other than myself
    Program, newspaper magazine: Medical tribune
    高知大学病院薬剤部の石田智滉氏らは、高知県内の急性非代償性心不全(ADHF)患者のレジストリであるKochi YOSACOI研究のデータを解析した結果、「入院時に便秘を合併していたADHF患者の2年生存率は便秘非合併患者と比べ有意に短かった」とFront Cardiovasc Med(2025; 11: 1470216)に報告した。


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.